Compass Wealth Management LLC Sells 4,300 Shares of CVS Health Corporation (NYSE:CVS)

Compass Wealth Management LLC lessened its stake in CVS Health Corporation (NYSE:CVS) by 51.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,084 shares of the pharmacy operator’s stock after selling 4,300 shares during the period. Compass Wealth Management LLC’s holdings in CVS Health were worth $277,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Hopwood Financial Services Inc. bought a new stake in shares of CVS Health in the fourth quarter valued at about $29,000. McIlrath & Eck LLC lifted its stake in shares of CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 174 shares during the period. Sierra Ocean LLC raised its position in CVS Health by 584.8% in the first quarter. Sierra Ocean LLC now owns 719 shares of the pharmacy operator’s stock worth $49,000 after purchasing an additional 614 shares in the last quarter. MV Capital Management Inc. raised its position in CVS Health by 63.9% in the first quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator’s stock worth $50,000 after purchasing an additional 289 shares in the last quarter. Finally, Dunhill Financial LLC raised its position in CVS Health by 147.2% in the first quarter. Dunhill Financial LLC now owns 749 shares of the pharmacy operator’s stock worth $51,000 after purchasing an additional 446 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of CVS Health stock in a transaction on Thursday, June 5th. The shares were purchased at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director owned 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.22% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on CVS shares. Jefferies Financial Group increased their price target on shares of CVS Health from $74.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, June 30th. Royal Bank Of Canada increased their price target on shares of CVS Health from $74.00 to $81.00 and gave the stock an “outperform” rating in a research report on Monday, May 5th. Truist Financial increased their price target on shares of CVS Health from $82.00 to $84.00 and gave the stock a “buy” rating in a research report on Monday, May 12th. Cowen reissued a “buy” rating on shares of CVS Health in a research report on Monday, May 5th. Finally, Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $75.06.

CVS Health Stock Performance

Shares of CVS Health stock opened at $67.38 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. The firm has a market cap of $85.23 billion, a P/E ratio of 16.08, a P/E/G ratio of 0.97 and a beta of 0.57. The firm has a 50 day simple moving average of $65.11 and a 200 day simple moving average of $61.58. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $72.51.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same quarter last year, the business posted $1.31 earnings per share. CVS Health’s revenue for the quarter was up 7.0% compared to the same quarter last year. Sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.